1. Home
  2. BFRI vs KDLY Comparison

BFRI vs KDLY Comparison

Compare BFRI & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRI
  • KDLY
  • Stock Information
  • Founded
  • BFRI 1997
  • KDLY 2019
  • Country
  • BFRI United States
  • KDLY United States
  • Employees
  • BFRI N/A
  • KDLY N/A
  • Industry
  • BFRI Biotechnology: Pharmaceutical Preparations
  • KDLY
  • Sector
  • BFRI Health Care
  • KDLY
  • Exchange
  • BFRI Nasdaq
  • KDLY NYSE
  • Market Cap
  • BFRI 6.2M
  • KDLY 5.8M
  • IPO Year
  • BFRI 2021
  • KDLY 2024
  • Fundamental
  • Price
  • BFRI $0.76
  • KDLY $0.97
  • Analyst Decision
  • BFRI Strong Buy
  • KDLY
  • Analyst Count
  • BFRI 1
  • KDLY 0
  • Target Price
  • BFRI $7.00
  • KDLY N/A
  • AVG Volume (30 Days)
  • BFRI 7.3M
  • KDLY 404.5K
  • Earning Date
  • BFRI 11-13-2024
  • KDLY 11-12-2024
  • Dividend Yield
  • BFRI N/A
  • KDLY N/A
  • EPS Growth
  • BFRI N/A
  • KDLY N/A
  • EPS
  • BFRI N/A
  • KDLY N/A
  • Revenue
  • BFRI $35,358,000.00
  • KDLY $2,875,400.00
  • Revenue This Year
  • BFRI $19.11
  • KDLY N/A
  • Revenue Next Year
  • BFRI $20.16
  • KDLY N/A
  • P/E Ratio
  • BFRI N/A
  • KDLY N/A
  • Revenue Growth
  • BFRI 5.17
  • KDLY N/A
  • 52 Week Low
  • BFRI $0.61
  • KDLY $0.78
  • 52 Week High
  • BFRI $4.04
  • KDLY $4.20
  • Technical
  • Relative Strength Index (RSI)
  • BFRI 43.25
  • KDLY N/A
  • Support Level
  • BFRI $0.65
  • KDLY N/A
  • Resistance Level
  • BFRI $0.79
  • KDLY N/A
  • Average True Range (ATR)
  • BFRI 0.11
  • KDLY 0.00
  • MACD
  • BFRI -0.01
  • KDLY 0.00
  • Stochastic Oscillator
  • BFRI 26.41
  • KDLY 0.00

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: